Synthesis of Antimicrobial Norlabdane Compounds with Rearranged Cycle B and Molecular Docking Studies
Molecules · 03.12.2024 · 29 (23) · 5714
DOI: 10.3390/molecules29235714 ↗Kurz gefasst
Fachartikel in der Zeitschrift Molecules, online erschienen am 03.12.2024. Verfasst von Alexandru Ciocarlan und 6 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Chemistry, Moldova State University, 2028 Chisinau, Moldova. Hauptthemen laut MEDLINE: Molecular Docking Simulation, Microbial Sensitivity Tests. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 31 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: State University of Moldova, Institutional Research Program of the Moldova State University (MSU).
Abstract (Originalsprache)
The synthesis of tetra- and pentanorlabdane compounds with rearranged cycle B based on commercially available (+)-sclareolide is reported. Desired compounds were prepared from intermediate ketones via Baeyer–Villiger oxidation. The structures of synthesized compounds were confirmed by spectral IR, 1D (1H, 13C, and DEPT), and 2D (H-COSY, H,C-HSQC, H,C-HMBC, H,N-HMBC, NOESY) NMR analyses, mass-spectrometry and single crystal X-rays diffraction. Two out of the four synthesized compounds showed high antifungal and antibacterial activities comparable to and exceeding standard antifungal (caspofungin) and antibacterial (kanamycin) agents. DFT calculations show that in gas and DCM, compound 4 is more stable than 3 with a difference in the Gibbs free energy of 23.3 kJ/mol and 20.7 kJ/mol, respectively. In water and methanol, compound 3 is slightly more stable, by 2.4 kJ/mol and 2.78 kJ/mol, respectively. Molecular docking to four targets DNA gyrase from E. coli (1KZN), Fabz from P. aeruginosa (1U1Z), dihydrofolate reductase from C. albicans (3QLS) and MurB from E. coli (2Q85) showed good agreement with the results of in vitro evaluation and confirmed the biological activity of compounds 3 and 4, with binding affinities comparable and for some targets exceeding that of Caspofungin and Kanamycin.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Institute of Chemistry, Moldova State University, 2028 Chisinau, Moldova.
- "P. Poni" Institute of Macromolecular Chemistry, 700487 Iasi, Romania.
- Metropolitan Center of Research T.A.B.O.R. (Tehnologie Arta Biserica Ortodoxa Romana), 700066 Iasi, Romania.
ORCID-Profile: Sergiu Shova, Nicoleta Vornicu, Veaceslav Kulcitki
Förderung
- State University of Moldova
- Institutional Research Program of the Moldova State University (MSU)
Zitieren
APA
Ciocarlan, A., Lungu, L., Shova, S., Vornicu, N., Bolocan, N., Kulcitki, V., & Aricu, A. (2024). Synthesis of Antimicrobial Norlabdane Compounds with Rearranged Cycle B and Molecular Docking Studies. Molecules, 29(23), 5714. https://doi.org/10.3390/molecules29235714
Vancouver
Ciocarlan A, Lungu L, Shova S, Vornicu N, Bolocan N, Kulcitki V, et al. Synthesis of Antimicrobial Norlabdane Compounds with Rearranged Cycle B and Molecular Docking Studies. Molecules. 2024;29(23):5714. doi:10.3390/molecules29235714
BibTeX
@article{Ciocarlan2024,
author = {Ciocarlan, Alexandru and Lungu, Lidia and Shova, Sergiu and Vornicu, Nicoleta and Bolocan, Natalia and Kulcitki, Veaceslav and Aricu, Aculina},
title = {Synthesis of Antimicrobial Norlabdane Compounds with Rearranged Cycle B and Molecular Docking Studies},
journal = {Molecules},
year = {2024},
volume = {29},
number = {23},
pages = {5714},
doi = {10.3390/molecules29235714}
}
EUVIMED